Integrating Optical Genome Mapping into the Genetic Diagnostic Algorithm: Clinical Utility in Unresolved Autosomal Recessive Disorders from a Large Cohort
Cytogenetic and Genome Research · 2026
DOI: 10.1159/cgr/achag002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytogenetic and Genome Research, 2026. Verfasst von Ozge Beyza Gundogdu Ogutlu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Gazi University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Genes, Recessive, Algorithms, Chromosome Mapping, Genetic Diseases, Inborn. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Scientific Research Projects Coordination Unit (BAP).
Abstract (Originalsprache)
Introduction
The identification of precise genetic etiologies is indispensable for the clinical management of monogenic disorders. However, conventional diagnostic methods and exome sequencing (ES) frequently fail to identify complex structural variations (SVs), leaving the genetic basis unexplained in approximately 30–60% of suspected cases. Optical genome mapping (OGM) emerges as a high-resolution technology capable of detecting cryptic SVs inaccessible to standard methodologies.
Methods
In this study, we evaluated the clinical utility of integrating OGM into the diagnostic algorithm for unresolved monogenic diseases. Following negative or inconclusive results from standard ES pipelines, OGM was applied to a targeted subset of patients (n = 7) selected from a comprehensive clinical cohort of 1,257 individuals with suspected genetic disorders.
Results
The integration of OGM identified candidate SVs that may represent the second allelic alteration in two distinct cases; however, confirmation through parental segregation analysis remains pending. Specifically, OGM identified an intronic insertion in the TTLL5 gene and a deletion in a putative regulatory region approximately 400 kb upstream of the NMNAT1 gene, both of which were missed by prior diagnostic testing.
Conclusion
Our findings suggest that OGM has potential value in investigating the missing heritability of autosomal recessive disorders. By detecting candidate SVs invisible to conventional methods, OGM may warrant consideration as a complementary diagnostic approach following inconclusive ES; however, larger cohorts and confirmatory functional studies are needed to establish its clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, Faculty of Medicine, Gazi University, Ankara, Türkiye.
- Department of Medical Genetics, Ankara Etlik City Hospital, Ankara, Türkiye.
- Department of Medical Biology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Türkiye.
- Department of Medical Genetics, Detagen Genetic Diseases Evaluation Center, Kayseri, Türkiye.
- Department of Ophthalmology, Faculty of Medicine, Gazi University, Ankara, Türkiye.
- Genetic Diseases Evaluation Center, Memorial Bahçelievler Hospital, Istanbul, Türkiye.
Förderung
- Scientific Research Projects Coordination Unit (BAP)
Zitieren
APA
Gundogdu Ogutlu, O. B., Kazan, H. H., Mutlu, M. B., Ergun, M. A., Ozdek, S., & Kayhan, G. (2026). Integrating Optical Genome Mapping into the Genetic Diagnostic Algorithm: Clinical Utility in Unresolved Autosomal Recessive Disorders from a Large Cohort. Cytogenetic and Genome Research. https://doi.org/10.1159/cgr/achag002
Vancouver
Gundogdu Ogutlu OB, Kazan HH, Mutlu MB, Ergun MA, Ozdek S, Kayhan G. Integrating Optical Genome Mapping into the Genetic Diagnostic Algorithm: Clinical Utility in Unresolved Autosomal Recessive Disorders from a Large Cohort. Cytogenetic and Genome Research. 2026. doi:10.1159/cgr/achag002
BibTeX
@article{GundogduOgutlu2026,
author = {Gundogdu Ogutlu, Ozge Beyza and Kazan, Hasan Huseyin and Mutlu, Mehmet Burak and Ergun, Mehmet Ali and Ozdek, Sengul and Kayhan, Gulsum},
title = {Integrating Optical Genome Mapping into the Genetic Diagnostic Algorithm: Clinical Utility in Unresolved Autosomal Recessive Disorders from a Large Cohort},
journal = {Cytogenetic and Genome Research},
year = {2026},
doi = {10.1159/cgr/achag002}
}
EUVIMED